Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Development and physicochemical characterization of solid dispersions containing praziquantel for the treatment of schistosomiasis

Texto completo
Autor(es):
Dametto, P. R. ; Dametto, A. C. ; Polese, L. ; Ribeiro, C. A. ; Chorilli, M. ; de Freitas, Osvaldo
Número total de Autores: 6
Tipo de documento: Artigo Científico
Fonte: JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY; v. 127, n. 2, p. 1693-1706, FEB 2017.
Citações Web of Science: 3
Resumo

Praziquantel (PZQ) is an anthelminthic agent active against parasitic flatworms of the Schistosoma type and the most important drug for the treatment and morbidity control of schistosomiasis. In this study, a high-performance liquid chromatography method was employed for quantification of PZQ in the physical mix (PM) and solid dispersion (SD) prepared by Fusion Method utilizing the carriers Gelucire(A (R)) 50/13 and mannitol in ratio 3:1; 1:1; 1:3 PZQ/carrier. Furthermore, PM and SD were characterized by Thermogravimetry-Differential Thermal Analysis, Differential Scanning Calorimetry, Infrared Spectroscopy, X-Ray Diffraction, and Scanning Electron Microscopy. Solubility assay was made to evaluate the solubility of PZQ in purified water, in 0.1 mol L-1 HCl solution and 0.2 mol L-1 buffered phosphate solution. PZQ dissolution test was carried out in 0.1 mol L-1 HCl and 0.2 M buffered phosphate (pH 6.8). The interaction between PZQ and carriers in PMs and SDs was evidenced due to experimental enthalpy, which was different from expected enthalpy. However, this interaction did not affect the solubility of the drug. In PZQ dissolution test, the best result was for SD 1:1 PZQ/Gelucire, which presented higher dissolution rate and release extension than PM and PZQ. Thus, SD may be a strategy to enhance the solubility and dissolution, a crucial step in the development of a pharmaceutical dosage form containing PZQ for possible application in the treatment of schistosomiasis. (AU)

Processo FAPESP: 11/11586-0 - Dispersões sólidas como estratégia para aumentar a disponibilidade de fármacos pouco solúveis
Beneficiário:Patrícia Roberta Dametto
Modalidade de apoio: Bolsas no Brasil - Pós-Doutorado